Derivative UV-Vis spectrophotometry for porphyrins interactions in photodynamic therapy

Analytical Letters

Volumn 43, Issue 7, 2010, Pages 1277-1286

  Ion, Rodica Mariana ^a,b  

^a VALAHIA UNIVERSITY OF TARGOVISTE   (Romania)

^b NATIONAL RESEARCH AND DEVELOPMENT INSTITUTE FOR CHEMISTRY AND PETROCHEMISTRY ICECHIM   (Romania)

Author keywords

Derivative UV Vis; DNA; Melting; Optical absorption; Porphyrins

Indexed keywords

EID: 77952606447     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710903518690     Document Type: Article

References (26)

1. Agostinis, P., E. Buytaert, H. Breyssens, and N. Hendrickx. 2004. Regulatory pathways in photodynamic therapy induced apoptosis. Photochem. Photobiol. Sci. 3: 721-727.
2. Alexandrova, R., R. M. Ion, E. V. Stoykova, and S. Shurulinkov. 2003. In vitro investigation on cytotoxic activity of TS4PP [5,10,15,20-tetra(4-sulfophenyl) porphyrin]. Proceedings of SPIE 5226: 423-427.
3. Allison, R. R., G. H. Downie, R. Cuenca, X.-H. Hu, C. J. H. Childs, and C. H. Sibata. 2004. Photosensitizers in clinical PDT. Photodiagnosis and Photodynamic Therapy. 1: 27-32.
4. Almeida, R. D., B. J. Manadas, A. P. Carvalho, and C. B. Duarte. 2004. Intracellular signaling mechanisms in photodynamic therapy. Biochim. Biophys. Acta. 1704: 59-65.
5. Antonov, L., and D. Nedeltcheva. 2000. Resolution of overlapping UV-Vis absorption bands and quantitative analysis. Chem. Soc. Rev. 29: 217-227.
6. Barltrop, J. A. 1991. 5-(3-carboxymethoxyphenyl)-2-(4,5-dimenthylthiazoly)-3-(4-sulfophenyl) tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water soluble formazans as cellviability indicators. Bioorg. Med. Chem. Lett. 1: 611-615.
7. Brown, S. B., E. A. Brown, and I. Walker. 2004. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 5: 497-480.
8. Foote, C. S. 1978. Mechanisms of Photo oxidation. In Singlet Oxygen reactions with organic compounds and polymers, eds. J. F. Ranby and J. F. Rabek, 135-146. New York: John Willey and Sons.
9. Frackowiak, D., A. Planner, R. M. Ion, and K. Wiktorowicz. 1998. Incorporation of dye in resting and stimulated leukocytes, 87-114. In Near-infrared dyes for high technology applications, eds. E. Daehn, U. Resch-Genger, and O. Wolfbeis. NATO ASI SERIES, Vol. 3/52., Dordrecht/Boston/London: Kluwer Academic Publishers.
10. Henderson, B. H., and T. J. Dougherty. 1992. Photodynamic therapy: basic principles and clinical applications. New York: Marcel Dekker.
11. Ion, R. M. 2000. Porphyrins for tumor destruction in photodynamic therapy. Current Topics in Biophysics 24: 21-34.
12. Ion, R. M. 2003. Porphyrins and photodynamic therapy of cancer. 138, Bucharest: FMR.
13. Ion, R. M. 2006. Photochemistry. Priciples, and applications, Vol. 2. Bucharest: FMR.
14. Ion, R. M., M. Grigorescu, F. Scarlat, V. I. R. Niculescu, and Fl. Scarlat. 2001. Porphyrins sensitization of DNA. Romanian Journal of Physics 46(9-10): 633-641.
15. Ion, R. M., M. A. Ionita, B. Carstocea, M. L. Pascu, L. Danaila, and A. Bucur. 2004. Clinical aspects of photodynamic therapy-Romanian experience. Oftalmologia 48: 53-61.
16. Ion, R.-M., A. Planner, K. Wiktorowicz, and D. Frackowiak. 1998. The incorporation of various porphyrins into blood cells measured via flow cytometry, absorption and emission spectroscopy. Acta Biochimica Polonica 45: 833-845.
17. Kessel, K. 2004. Photodynamic therapy: from the beginning. Photodiagnosis and Photodynamic Therapy 1: 3-10.
18. Marcus, S. L., and W. R. Mcintyre. 2002. Photodynamic therapy systems and applications. Expert Opin. Emerg. Drugs. 7: 321-329.
19. Moan, J., K. Berg, and E. Kvam. 1990. Effects of photodynamic treatment on DNA and DNA related cell functions. In Photodynamic. Therapy of neoplastic disease. Vol. I, 197-207, ed. D. Kessel. Boca Raton, FL: CRC Press.
20. Moor, A. C. 2000. Signaling pathways in cell death and survival after photodynamic therapy. J. Photochem. Photobiol. 57: 1-9.
21. Neagu, M., G. Manda, C. Constantin, E. Radu, and R. M. Ion. 2007. Synthetic porphyrins in experimental photodynamic therapy induce a different anti tumoral effect. J. Porphyrins Phthalocyanines 11: 58-65.
22. Nowis, D., M. Makowski, T. Stokłosa, M. Legat, T. Issat, and J. Goła̧b. 2005. Direct tumor damage mechanisms of photodynamic therapy. Acta Biochimica Polonica 52: 339-345.
23. Plaetzer, K., T. Kiesslich, T. Verwanger, and B. Krammer. 2003. The modes of cell death induced by PDT: an overview. Med. Laser. Appl. 18: 7-19.
24. Shampa, R., S. R. Chatterjee, T. S. Srivastava, J. P. Kamat, and T. P. A. Devasagayam. 1998. Photocleavage of Plasmid pBR322 DNA by Some Anionic Porphyrins. J. Porphyrins Phthalocyanines (JPP) 2: 337-343.
25. Talsky, G. 1994. Derivative Spectrophotometry. Low and Higher Order. Weinheim, Germany: VCH.
26. Vancikova, Z. 1998. Principles of the photodynamic therapy and its impact on the immune system. Sb. Lek. 99: 1-12.